Histamil

Quick links to important sections

Histamil

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Histamil

Histamil is a synthetic drug and a single-ingredient product used for the systemic relief of allergic symptoms. It belongs to the first-generation antihistamine class and contains the active ingredient Chlorphenamine maleate.


Quick Facts

Property Description
Active ingredient Chlorphenamine maleate
Forms Tablets, Syrup, Injection
Pharmacological class First-generation H1 Antagonist
General purpose Symptomatic relief of allergic discomfort
Origin Synthetic alkylamine derivative

What Type of Medicine is Histamil?

Histamil is classified as a first-generation antihistamine H1 receptor antagonist, which acts as an alkylamine derivative. Its main, high-level purpose is to manage the general discomfort and irritation caused by the body's overreaction to allergens, serving as a form of symptomatic treatment. The substance, Chlorphenamine maleate, is structurally characterized by a propyl-substituted alkylamine chain. As a long-established, synthetic drug, it is well-known for providing comprehensive, systemic relief from various hypersensitivity reactions. This action is clinically recognized for its efficacy in providing relief, often used in scenarios involving acute histamine release, such as seasonal allergy flare-ups.


Composition and Available Forms

The basic composition of the Histamil brand is centered around the active ingredient Chlorphenamine maleate combined with standard pharmaceutical excipients necessary for the specific dosage form. The compound Chlorphenamine is often formulated as the maleate salt to enhance stability. This medication is available in several pharmaceutical preparations to facilitate varying needs, including tablets, syrup (oral solution), and injection (parenteral formulation). For instance, the syrup is designed with a specific positioning toward pediatric use, and its liquid form facilitates precise dosing for children. The fact that Histamil is available in multiple forms means it can be used flexibly across different clinical settings.


The General Purpose of an H1 Antagonist

The general purpose of Histamil is to counteract the effects of histamine within the body through histamine H1 receptor blockade. By preventing histamine—a chemical released during an allergic reaction—from binding to its receptors, Histamil intervenes early in the process. This antiallergic action alleviates the cascade of effects that lead to general allergic distress, offering relief from irritation and discomfort associated with allergic conditions. This function allows the medicine to offer a rapid systemic effect, often positioning it for relief from sudden, acute allergic episodes.

What side effects are possible with Histamil?

Possible Side Effects and Safety Information

The documented safety profile for Histamil (Chlorphenamine maleate) reflects its classification as a first-generation H1 antagonist, which is associated with both central nervous system (CNS) and anticholinergic effects, as reported in official prescribing information.

Frequency-Classified Adverse Reactions

Adverse reactions are classified by frequency based on governmental regulatory data. Drowsiness and dry mouth are designated as Very Common effects. Effects designated as Common include dizziness, blurred vision, constipation, fatigue, and difficulty with urination (urinary retention). Rare but serious effects are also documented.

System-Organ Specific Adverse Reactions

Official labels group documented effects according to the physiological system involved:

  • Nervous System: Sedation, somnolence, and dizziness are frequently reported. Paradoxical effects, such as excitation and restlessness, have also been documented.
  • Gastrointestinal and Eye: Common effects include dry mouth, constipation, and blurred vision, which are linked to the drug's anticholinergic properties.
  • Blood and Lymphatic System: Rare but serious documented effects include changes in blood components, specifically agranulocytosis and hemolytic anemia.

Safety Considerations and Restrictions

The onset of effects like drowsiness and sedation is noted as generally more pronounced at the start of treatment. Regulatory text highlights that Older Adults may be more susceptible to CNS effects like confusion, as well as urinary retention. Children are noted for a greater incidence of paradoxical excitation. Safety-related limitations advise caution in individuals with conditions aggravated by anticholinergic effects, such as narrow-angle glaucoma or prostatic hypertrophy.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Histamil (Chlorphenamine maleate) is associated with serious, officially documented manifestations that require immediate medical intervention.

Documented Manifestations and Severe Outcomes

An overdose primarily affects the central nervous system (CNS), which may present with a dual profile: either profound CNS depression, resulting in drowsiness, sedation, or coma, or paradoxical CNS stimulation, characterized by excitement, tremors, convulsions, or psychoses. The latter presentation (stimulation) is more likely to occur in children and the elderly. Anticholinergic effects such as mydriasis and urinary retention are also documented. Overdose can escalate to severe or life-threatening outcomes including cardiovascular collapse, arrhythmias, and respiratory failure.

Required Emergency Action

Governmental regulatory guidance mandates that anyone who suspects an overdose must seek emergency medical attention or call a Poison Help line immediately. You must contact the nearest hospital or doctor immediately once any overdosage symptoms are experienced.

Management and Treatment Principles

Management is defined as symptomatic and supportive measures. No specific antidote is available for Chlorphenamine maleate overdose. Official protocols require special attention to cardiac, respiratory, renal, and hepatic functions, and may involve the consideration of activated charcoal if the overdose was recent and taken orally.

Therapeutic Uses of Histamil

Main Uses and Benefits of Histamil

Histamil, containing the active ingredient astemizole, is a long-acting antihistamine. It is primarily used to manage symptoms associated with allergic reactions. By blocking the action of histamine—a substance in the body that causes allergic symptoms—it helps provide relief from various conditions.

Seasonal and Perennial Allergic Rhinitis

Histamil is used to treat symptoms of allergic rhinitis, commonly known as hay fever. This includes both seasonal allergies triggered by pollen and perennial allergies caused by indoor allergens like dust mites or animal dander. Key symptoms addressed include:

  • Sneezing: Reducing the frequency and severity of sneezing fits.
  • Rhinorrhea: Minimizing nasal discharge or a runny nose.
  • Nasal Congestion: Helping to ease the feeling of a blocked nose.
  • Itching: Alleviating itching in the nose, throat, and roof of the mouth.

Allergic Conjunctivitis

In addition to nasal symptoms, Histamil is utilized to manage allergic reactions affecting the eyes. This condition often occurs alongside allergic rhinitis and is characterized by:

  • Redness of the eyes.
  • Excessive tearing or watery eyes.
  • Itching and burning sensations in the ocular area.

Chronic Urticaria and Dermatological Conditions

Histamil is also indicated for the treatment of chronic idiopathic urticaria, a condition characterized by the regular appearance of hives (wheals) and skin welts for which there is no identifiable cause. The benefits in dermatological contexts include:

  • Reduction of Hives: Decreasing the number and size of raised skin welts.
  • Pruritus Relief: Significantly reducing the intense itching associated with hives and other allergic skin disorders.
  • Symptom Management: Aiding in the management of other allergic dermatoses where histamine release is a primary factor.

Regulatory References

  1. Chlorpheniramine: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Histamil, a second-generation H1 receptor antagonist, is commonly used to treat symptoms associated with allergic rhinitis (hay fever) and chronic urticaria (hives). Like all medications, its use is guided by safety considerations for specific populations and pre-existing health conditions.

Who Can Use Histamil?

It is typically safe for use in adults and children aged 12 years and older. In certain formulations and at reduced doses, it may be prescribed for children as young as six years old for the relief of allergy symptoms. Elderly patients can generally use Histamil, although they may require dosage adjustments if they have impaired kidney or liver function, as they can be more susceptible to side effects.

Who Should Use Histamil with Caution?

Population / Condition Guidance
Pregnancy Use only if clearly needed and the benefit outweighs the potential risk. Second-generation antihistamines are often preferred. Consult a physician.
Breastfeeding Small amounts may pass into breast milk. Use only if a physician determines the potential benefit justifies the risk to the infant.
Impaired Kidney or Liver Function Reduced doses may be necessary, as the body's ability to clear the medication may be decreased.
Known Allergy Do not use if there is a known hypersensitivity or allergic reaction to Histamil or its components.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Histamil highlights specific categories of medicines and products that require professional consultation or avoidance due to documented interactions.


Interacting Drug Categories and Products

Category/Product Interaction Type and Constraint
Monoamine Oxidase Inhibitors (MAOIs) Prohibited use; consult a healthcare professional.
Alcoholic Beverages Avoid concurrent use.
Sedatives and Tranquilizers Requires consultation before use; potential for increased drowsiness.
Prescription drugs for High Blood Pressure or Depression Requires consultation before use.

Official Interaction Guidance

Histamil is documented to interact with substances that affect the central nervous system, which may increase certain effects. It is required to avoid alcoholic beverages entirely, as this combination may increase drowsiness. Concurrently taking Histamil with sedatives or tranquilizers is a use-with-caution interaction that mandates asking a doctor or pharmacist beforehand due to the potential for increased drowsiness. Furthermore, professional consultation is required before taking this product with prescription drugs for high blood pressure or depression. These regulatory statements structure the official interaction profile around CNS depressants and specific chronic care medications, defining the necessary constraints for use.

Mechanism of Action

Histamil functions primarily as a selective inverse agonist at the Histamine H1 receptor (H1). The H1 receptor is a G-protein coupled receptor (GPCR) predominantly coupled to the Gq/11 signaling pathway.

Upon binding to the H1 receptor, Histamil stabilizes the receptor in an inactive conformation. This action not only competitively blocks the binding of the endogenous agonist, histamine, but also suppresses the intrinsic constitutive activity of the receptor. This inverse agonism prevents the Gq/11 protein activation, thereby inhibiting the subsequent downstream cascade. This cascade typically involves the stimulation of phospholipase C (PLC), leading to the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol trisphosphate (IP3) and diacylglycerol (DAG). Consequently, the drug impedes the IP3-mediated release of intracellular calcium (Ca^2+) and the DAG-mediated activation of protein kinase C (PKC).

At the system level, by modulating H1 receptor activity on peripheral smooth muscle and endothelial cells, the drug reduces H1-mediated increases in capillary permeability and vasodilation, and decreases the contraction of various smooth muscle groups.

Dosage and Administration Information

Histamil is administered through either oral or parenteral routes, depending on the required systemic use pattern. The oral route is applied for routine symptomatic use and includes immediate-release (IR) tablets, extended-release forms, and syrup. The Intravenous (IV), Intramuscular (IM), and Subcutaneous (SC) routes are approved for the injection formulation, typically when a rapid systemic effect is desired.

The standard adult dose for the IR oral form is 4 mg every 4 to 6 hours, with the total dose not exceeding 24 mg in a 24-hour period. For the injection, a dose of 10 mg to 20 mg is used, with a maximum limit of 40 mg per 24 hours. A lower maximum daily dose, such as 12 mg, is advised for older adults. The medicine can be taken with or without food.

When administering the syrup, an accurate measuring device must be used, rather than a household spoon, to ensure dose precision. If the medicine is administered via the IV route, the injection must be given slowly over a period of one minute. For pediatric patients aged 6 to 12 years, the dose is 2 mg every 4 to 6 hours, not to exceed 12 mg daily. Histamil is intended for short-term use; continuous administration should not exceed a two-week period without professional review. If a dose is missed, it should be skipped if it is nearly time for the next scheduled dose.

Recent Clinical Evidence

Histamil: Recent Clinical Evidence

Evidence for Symptomatic Relief of Allergic Rhinitis and Allergic Conjunctivitis

Research examined Histamil in the context of conditions characterized by fluctuating or episodic manifestations, such as hay fever and allergic eye conditions. The evidence base includes Randomized Controlled Trials (RCTs) and is summarized in Systematic Reviews. This medication is observed in established official health documents known as Over-the-Counter (OTC) monographs from regulatory bodies.

Studies monitored outcomes related to systemic or functional imbalance, such as the patient-reported severity of a runny nose, sneezing, and itching/watering of the eyes. Research also examined patterns related to how the drug's properties as a first-generation antihistamine relate to outcomes reflecting daily functioning or activity level. The evidence quality varies across studies, as much of the foundational data for this established medication comes from older trials.

Evidence for Relief of Acute and Chronic Skin Hypersensitivity

Histamil was studied for its role in exploring symptom change in skin-related allergic responses, specifically in conditions involving outcomes capturing phases of heightened symptom activity like hives (urticaria). Research examined outcomes related to physical discomfort, such as the severity of itching and changes in the visibility and size of skin lesions. Studies monitored responses over defined time intervals for conditions characterized by fluctuating or episodic manifestations, such as Chronic Spontaneous Urticaria (CSU).

Follow-up Duration and Evidence Gaps

Clinical trials focusing on core indications have follow-up durations that were typically limited to short-term periods. There is limited information for long-term outcomes regarding the sustained symptomatic change, and the durability of symptom patterns is generally not fully established through contemporary, large-scale RCTs. Research has explored the use of Chlorphenamine maleate in pediatric populations but data for certain groups remain insufficient in the modern research landscape. The sample sizes were modest in some of the more recent pilot trials, and the full extent of the drug’s characteristic functional impact remains an area where studies continue to monitor patterns. Research does not determine whether an individual will respond similarly, as findings describe group patterns, not personal outcomes.

Key Studies & References

  1. Efficacy of first-generation H1-antihistamines in chronic urticaria: a systematic review
  2. WHO Model List of Essential Medicines

Frequently Asked Questions (FAQ)

Common questions about Histamil (FAQ)

Q: Can Histamil affect sleep?

Official product information notes that very common side effects include drowsiness and sedation. The drug may also cause effects such as restlessness or insomnia (difficulty sleeping). These central nervous system effects may interfere with an individual’s normal sleep patterns.

Q: Are there any specific foods to avoid while using Histamil?

Regulatory documents explicitly state the need to avoid alcoholic beverages while using this medicine, as this can increase side effects like drowsiness. Official product information typically does not list restrictions for specific common foods.

Q: Is it okay to drive after taking Histamil?

Official labeling states caution is advised when driving a motor vehicle or operating machinery. Because Histamil can commonly cause side effects such as drowsiness and dizziness, regulatory information advises that individuals assess their own response before engaging in tasks that require full attention.

Q: How quickly does Histamil start to work?

Clinical information indicates that effects are often observed within 30 minutes to one hour after administration. This rapid onset contributes to its use for quick symptomatic relief.

Q: How long does the effect of Histamil last?

The effect for immediate-release forms is generally associated with the recommended dosing interval. Official regulatory information defines the dosing interval as typically every 4 to 6 hours for symptomatic relief. Extended-release formulations, where available, are designed to last longer.

Q: Are there known interactions between Histamil and cold remedies?

Regulatory warnings indicate that consultation with a healthcare professional is necessary before combining Histamil with other antihistamines or cold medicines. This caution is due to the potential for increased side effects associated with combining central nervous system depressants.

Q: What is the difference between a common side effect and a serious one for Histamil?

Regulatory sources generally categorize adverse effects based on frequency in clinical trials and reports. Common effects, like dry mouth and drowsiness, are frequently reported. Serious effects are defined in official warnings as those that necessitate immediate notification of a healthcare professional (e.g., changes in blood components or fast heartbeat).

Q: Does Histamil contain corticosteroids?

No. The active ingredient listed in official drug labels is Chlorphenamine maleate. This substance is classified as a first-generation H1 antagonist (an antihistamine) and does not contain corticosteroids.

Q: Why is Histamil sometimes taken at night?

Histamil’s very common side effect of drowsiness and sedation is stated in regulatory documents. This characteristic is often utilized in products marketed for nighttime use to help manage cold and allergy symptoms that interfere with rest.

Q: Is there a generic version of Histamil available?

Yes. Regulatory documents confirm that the active ingredient in Histamil, Chlorphenamine maleate, is widely available in generic forms and under various brand names.

Q: What should I do if the medicine doesn't seem to be working?

Official regulatory warnings advise that users stop use and consult a healthcare provider if symptoms worsen or do not improve within a specific timeframe, such as seven days. This indicates the need for professional re-evaluation of the condition.

Q: Is Histamil commonly used for pet allergies?

Regulatory information states the drug is used for temporary relief of symptoms due to hay fever or other upper respiratory allergies. This general indication covers a range of environmental triggers that cause allergic symptoms, including animal dander.

Q: Does the research on Histamil include diverse populations?

Regulatory documents indicate that the drug’s safety profile has been reviewed across key demographic groups. The inclusion of specific warnings and dosing considerations for children and older adults (geriatric) indicates that these populations were addressed in the regulatory review.

Q: Is it true that Histamil has a low potential for dependency?

Official regulatory documents and labeling for single-ingredient Histamil generally do not list dependency or abuse potential as a characteristic of the drug. The focus is on risks associated with side effects like drowsiness and anticholinergic effects.

Q: Can Histamil be taken with other allergy medications?

Regulatory warnings state that consultation with a healthcare professional is advised before using Histamil with other antihistamines, due to the potential for increased side effects like drowsiness.

How should Histamil be stored and disposed of?

The official regulatory documents define mandatory conditions for the storage and disposal of Histamil (Chlorphenamine maleate).

Requirement Official Regulatory Statement
Storage Temperature Store at room temperature, generally between 15 C and 30 C (59 F and 86 F), not exceeding 30 C.
Environmental Protection Protect from light and excessive moisture. Do not store in high-humidity areas like the bathroom.
Container & Safety Keep in the original container, tightly closed. Must be stored out of the sight and reach of children.
Disposal Instructions Do not flush the medicine. Unused or expired product should be returned to a drug take-back program. If unavailable, the product must be mixed with an undesirable substance, sealed, and discarded in the household trash.

These constraints ensure product stability and prevent accidental exposure, strictly following government-approved labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Histamil found in:

A-Z Index: